| Dr Lindsey Ann Jackson, MD | |
|
119 Fairfield Ave, Bellevue, KY 41073-1184 | |
| (859) 431-0090 | |
| (859) 431-3168 |
| Full Name | Dr Lindsey Ann Jackson |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 9 Years |
| Location | 119 Fairfield Ave, Bellevue, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598148819 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 51680 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Elizabeth Ft Thomas | Fort thomas, KY | Hospital |
| St Elizabeth Edgewood | Edgewood, KY | Hospital |
| St Elizabeth Florence | Florence, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Summit Medical Group, Inc | 2163326240 | 693 |
News Archive
Capturing real-time reports of cancer patients' symptoms between doctor's visits has proven health benefits, but technology and cost barriers are getting in the way of widespread adoption of the practice, reports a University of North Carolina Lineberger Comprehensive Cancer Center researcher.
Scientists at Queen's University Belfast have shown that they can deliver a gene directly into breast cancer cells causing them to self-destruct, using an innovative, miniscule gene transport system, according to research published today in the International Journal of Pharmaceutics.
Comprehensive health reform proposals now before Congress could help the more than 13 million uninsured young adults ages 19-29 gain coverage, and such reforms would also help ensure that those who now have coverage would not lose it, according to a new Commonwealth Fund report.
Implicit Bioscience has announced that it has been awarded a US$16.34 million (AU$18.2million) contract payable over 37 months from the United States Defense Threat Reduction Agency (DTRA) to develop its clinical stage drug oglufanide disodium as a broad spectrum therapeutic for the treatment of a number of intracellularbacterial diseases.
› Verified 3 days ago
| Entity Name | Kentucky Medical Services Foundation, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326091448 PECOS PAC ID: 5698689909 Enrollment ID: O20031119000300 |
News Archive
Capturing real-time reports of cancer patients' symptoms between doctor's visits has proven health benefits, but technology and cost barriers are getting in the way of widespread adoption of the practice, reports a University of North Carolina Lineberger Comprehensive Cancer Center researcher.
Scientists at Queen's University Belfast have shown that they can deliver a gene directly into breast cancer cells causing them to self-destruct, using an innovative, miniscule gene transport system, according to research published today in the International Journal of Pharmaceutics.
Comprehensive health reform proposals now before Congress could help the more than 13 million uninsured young adults ages 19-29 gain coverage, and such reforms would also help ensure that those who now have coverage would not lose it, according to a new Commonwealth Fund report.
Implicit Bioscience has announced that it has been awarded a US$16.34 million (AU$18.2million) contract payable over 37 months from the United States Defense Threat Reduction Agency (DTRA) to develop its clinical stage drug oglufanide disodium as a broad spectrum therapeutic for the treatment of a number of intracellularbacterial diseases.
› Verified 3 days ago
| Entity Name | Summit Medical Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881026169 PECOS PAC ID: 2163326240 Enrollment ID: O20031120000738 |
News Archive
Capturing real-time reports of cancer patients' symptoms between doctor's visits has proven health benefits, but technology and cost barriers are getting in the way of widespread adoption of the practice, reports a University of North Carolina Lineberger Comprehensive Cancer Center researcher.
Scientists at Queen's University Belfast have shown that they can deliver a gene directly into breast cancer cells causing them to self-destruct, using an innovative, miniscule gene transport system, according to research published today in the International Journal of Pharmaceutics.
Comprehensive health reform proposals now before Congress could help the more than 13 million uninsured young adults ages 19-29 gain coverage, and such reforms would also help ensure that those who now have coverage would not lose it, according to a new Commonwealth Fund report.
Implicit Bioscience has announced that it has been awarded a US$16.34 million (AU$18.2million) contract payable over 37 months from the United States Defense Threat Reduction Agency (DTRA) to develop its clinical stage drug oglufanide disodium as a broad spectrum therapeutic for the treatment of a number of intracellularbacterial diseases.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lindsey Ann Jackson, MD Po Box 635283, Cincinnati, OH 45263-5283 Ph: (859) 431-0090 | Dr Lindsey Ann Jackson, MD 119 Fairfield Ave, Bellevue, KY 41073-1184 Ph: (859) 431-0090 |
News Archive
Capturing real-time reports of cancer patients' symptoms between doctor's visits has proven health benefits, but technology and cost barriers are getting in the way of widespread adoption of the practice, reports a University of North Carolina Lineberger Comprehensive Cancer Center researcher.
Scientists at Queen's University Belfast have shown that they can deliver a gene directly into breast cancer cells causing them to self-destruct, using an innovative, miniscule gene transport system, according to research published today in the International Journal of Pharmaceutics.
Comprehensive health reform proposals now before Congress could help the more than 13 million uninsured young adults ages 19-29 gain coverage, and such reforms would also help ensure that those who now have coverage would not lose it, according to a new Commonwealth Fund report.
Implicit Bioscience has announced that it has been awarded a US$16.34 million (AU$18.2million) contract payable over 37 months from the United States Defense Threat Reduction Agency (DTRA) to develop its clinical stage drug oglufanide disodium as a broad spectrum therapeutic for the treatment of a number of intracellularbacterial diseases.
› Verified 3 days ago
Michael P Schulte, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 119 Fairfield Ave, Suite R102, Bellevue, KY 41073 Phone: 859-431-0090 Fax: 859-431-3168 | |
Debra Schulte, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 119 Fairfield Ave, Suite R102, Bellevue, KY 41073 Phone: 859-431-0090 Fax: 859-431-3168 | |
Casie Wiley, MD, MPH Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1119 Fairfield Avenue, Bellevue, KY 41073 Phone: 859-431-0090 Fax: 859-431-3168 | |
Amanda M Evans, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 119 Fairfield Ave, Bellevue, KY 41073 Phone: 859-431-0090 Fax: 859-431-3168 | |
Jennifer Amy Adams, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 119 Fairfield Ave, Suite R102, Bellevue, KY 41073 Phone: 859-431-0090 Fax: 859-431-3168 | |
William R Hammons, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 119 Fairfield Ave, Suite R102, Bellevue, KY 41073 Phone: 859-431-0090 Fax: 859-431-3168 | |
Jeremy D Engel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 119 Fairfield Ave, Suite R102, Bellevue, KY 41073 Phone: 859-431-0090 Fax: 859-431-3168 |